The Malaysian government last week negotiated free trade agreements (FTAs) with the United States of America (via the Trans-Pacific Partnership Agreement or TPP) and the European Union (EU).
Caribbean companies will have access to European programs designed to support innovation among small and medium-sized enterprises (SMEs) under the Economic Partnership Agreement (EPA), according to a CARICOM trade specialist, who yesterday urged that Bahamian businesses should look to offer products or services "with a unique advantage that people are willing to pay a premium price for".
An influential American business lobby, the US Chamber of Commerce, has hit out at New Zealand's position on intellectual property rights in the TransPacific Partnership trade talks.
Drug patent restrictions by the United States and the European Union in trade negotiations with emerging countries will harm the Thai pharmaceutical industry and affect local patients, say researchers.
Unhappy with the absence of "open discussion" on the FTA, the Indian Drug Manufacturers' Association has said that intellectual property related issues should not be part of the FTA.
On the eve of the Trans-Pacific Partnership negotiations in Auckland, a leaked negotiating document has exposed a fundamental conflict between the US and New Zealand positions on intellectual property.
Fears have been raised that cheap life-saving anti-retroviral drugs may no longer be available in Kenya if a trade agreement between the EU and India is concluded.
The EU claims data exclusivity is required under international law. It is not. It also claims that there will be no harm to access to medicines. But other countries have learned the hard way how harmful it can be.
Not many farmers may know that there are trade negotiations under way with the European Union that may severely impact agriculture in Canada. Items such as food inspection, supply management, local food, Canadian Wheat Board and Plant Breeders Rights are all on the negotiating table.